353) erging from the literature, recognises at-risk populations and highlights opportunit |
354) The majority were from low-risk populations. |
355) -2019) acute/early infections in three at risk populations - MSM, high risk women (H |
356) ing in a greater number of vulnerable and risk populations of tuberculosis. |
357) hesized that a population-level polygenic risk score (PRS) can explain phenotypic va |
358) ed the predictive accuracy of a polygenic risk score (PRS) derived from a European a |
359) In the second stage, we use the baseline risk score from the first stage as a singl |
360) We find that the baseline risk score modifies the relative and absol |
361) Cardiac patients are at an increased risk to develop a severe illness if infect |
362) ressor exposures and personal factors and risk to foster methods for occupational cu |
363) by low bone mineral density and increased risk to osteoporotic fractures. |
364) included a plan to mitigate psychological risk to the researcher-suggesting a need f |
365) anders, with the aim of identifying novel risk variants associated with asthma susce |
366) Moreover, the risk variants underlying GWAS AD-associati |
367) r predicting both disease genes and their risk variants. |
368) se comparisons can identify the universal risk variants. |
369) associated with increasing numbers of at-risk alleles. |
370) The two APOL1 renal risk alleles (RRA) genotypes were associat |
371) om heterozygous to homozygous for disease risk alleles or non-risk alleles using a t |
372) , road test data analysis, system failure risk assessment, and safety effectiveness |
373) hat can be used to assist with diagnosis, risk assessment, and tracking of illness s |
374) insufficient knowledge about genetics and risk assessment, lack of access to genetic |
375) Animal models for risk-based decision making can increase me |
376) Animal models for risk-based decision making have been descr |
377) xplore the relationship between sleep and risk-based decision making in animals. |
378) problems but no increased eating disorder risk or reduced well-being. |
379) mans, frequently make decisions involving risk or uncertainty. |
380) effects reported i.e., protective effect, risk or without association. |
381) Low-risk patients exhibited elevated M1/M2-lik |
382) are no prognostic markers to identify at-risk patients. |
383) ial to enhance the identification of high-risk patients whilst reducing unnecessary |
384) single APOL1 RRA was associated with CKD risk (OR 4.42, 95% CI 1.49-13.15, p = 0.00 |
385) viremia was associated with increased CKD risk (OR 7.45, 95% CI 1.66-33.35, P = 0.00 |
|